Veracyte Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Buy

VCYT
Veracyte

Last Price:

$29.70

Seasonality Move:

18.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Veracyte Stock Forecast

Over the next 52 weeks, Veracyte has on average historically risen by 29.4% based on the past 11 years of stock performance.
Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Is Veracyte Stock Undervalued?

The current Veracyte [VCYT] share price is $29.71. The Score for VCYT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
VCYT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Veracyte Stock Go Up Next Year?

Over the next 52 weeks, Veracyte has on average historically risen by 29.4% based on the past 11 years of stock performance.

Veracyte Stock Rating

Buy

Veracyte (VCYT) is a Buy

Is Veracyte overpriced?

Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Veracyte Stock Price History

Is VCYT stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VCYT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

veracyte.com

52-Week Data

52-Week High:

47.32

52-Week Low:

19.73

Prediction Charts

Market Cap:

2.3B

Price in USD:

29.71

Volume:

1.5M

Beta:

1.56

Technical Analysis

SMA50:

31.32

SMA100:

36.58

SMA200:

34.88

52-Wk Change:

44.01%

Stock Predictions

Is Veracyte stock public?

Yes, Veracyte is a publicly traded company.
What is the Veracyte stock quote today?

The Veracyte stock price is 29.71 USD today.
How to buy Veracyte stock online?

You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	31.08	31.13	31.97	30.64
Apr-23	32.21	31.47	32.84	31.36
Apr-24	31.56	32.14	32.17	31.50
Apr-25	32.00	32.23	32.36	31.71
Apr-28	32.38	31.67	32.85	30.99
Apr-29	31.60	31.38	31.90	31.10
Apr-30	30.66	30.50	31.38	30.16
May-1	30.64	29.71	30.71	29.30
May-2	30.13	30.35	30.84	29.92
May-5	30.48	31.32	31.60	30.45
May-6	30.67	30.56	31.06	30.03
May-7	30.76	30.84	30.99	29.56
May-8	30.19	31.21	31.57	27.24
May-9	31.50	29.71	32.35	28.81

Veracyte Earnings

Veracyte Earnings Report: Per Share Veracyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Veracyte Forecast Revenue Growth

Veracyte Stock Analysis: Historical quarterly revenues per share for Veracyte and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.03 per share, an increase this year of $0.28 per share, and an increase next year of $0.01 per share.

* Veracyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.